Revision Skincare releases eye serum
Clinical distributor AestheticSource has launched the new Revox Line Relaxer for men and women wanting to reduce expression and under-eye lines.
Clinical distributor AestheticSource has launched the new Revox Line Relaxer for men and women wanting to reduce expression and under-eye lines.
Cosmeceutical brand PCA Skin has added the Hyaluronic Acid Overnight Mask to its portfolio.
A study conducted by the Department of Dermatology at the Feinberg School of Medicine, Northwestern University, has suggested that cannulas are less likely to cause a vascular occlusion than needles when injecting filler.
According to a study published in JAMA Dermatology the rate of psoriasis flares did not increase during or immediately after systemic corticosteroid treatment.
Global pharmaceutical company Galderma has received top-line results for its phase 2 study in the US on the efficacy and safety of a single dose of abobotulinumtoxinA versus placebo for the treatment of moderate to severe glabellar lines.
Research published in Scientific Reports journal has suggested that botulinum toxin (BoNT-A) could be used as an effective treatment for patients with depression.
A study from global pharmaceutical company Galderma has indicated that 95% of patients treated with Azzalure abobotulinum toxin A achieved high levels of satisfaction with two treatments per year.
Peer-reviewed medical journal Plastic and Reconstructive Surgery – Global Open has published a study conducted by the Academic Aesthetics Mastermind Group (AAMG) on the safety of tear trough treatment.
A clinical study evaluating the efficacy and safety of skincare line Emepelle has suggested positive improvements on menopausal skin.
A chemical peel aimed at improving the external appearance of the vagina has been launched into the UK, called the Pink Intimate System.